Mesenchymal Stem Cells (MSCs) in the Treatment of Leukemia

In recent years, there has been a growing interest in the use of mesenchymal stem cells (MSCs) in the treatment of leukemia. MSCs are a type of adult stem cell that can be found in a variety of tissues, including the bone marrow, adipose tissue, and cord blood. Unlike other types of stem cells, MSCs have the ability to differentiate into a variety of cell types, including bone, cartilage, and fat cells. This unique property makes MSCs a promising tool for the treatment of leukemia, a cancer of the blood and bone marrow. Leukemia is a cancer of the blood cells in which the body produces too many white blood cells. White blood cells are the cells that fight infection. In leukemia, the white blood cells do not function properly and eventually crowd out the healthy blood cells. This can lead to a number of problems, including anemia, bleeding, and infections. There are four main types of leukemia, each with its own set of symptoms and treatment options. The use of MSCs in the treatment of leukemia is still in the early stages of research. However, there have been promising results in animal studies. For example, one study showed that MSCs could be used to kill leukemia cells in mice. The MSCs were able to do this by producing a protein that specifically targeted the leukemia cells. In another study, MSCs were used to treat a type of leukemia called acute myeloid leukemia (AML). The MSCs were injected into the mice and then allowed to grow in the bone marrow. The MSCs were able to kill the leukemia cells and improve the survival of the mice. Although the research is still in its early stages, the use of MSCs in the treatment of leukemia shows promise. MSCs have the ability to kill leukemia cells while leaving healthy cells unharmed. This makes MSCs a potentially valuable tool in the fight against leukemia.

 "Mesenchymal stem cells in acute myeloid leukemia - NCBI." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779935/. Accessed 21 Oct. 2022.

 "Bone Marrow Mesenchymal Stem Cells Support Acute ... - PubMed." 3 Nov. 2020, https://pubmed.ncbi.nlm.nih.gov/32966766/. Accessed 21 Oct. 2022.

 "Mesenchymal stem cells in suppression or progression of ... - Nature." 31 Jan. 2019, https://www.nature.com/articles/s41375-018-0373-9. Accessed 21 Oct. 2022.

The information below is the recommended stem cell therapy protocol for this condition 

Route of AdministrationDoseTime (Days)Total Cells
IV100,000,0002200,000,000
Myers cocktail/NAD1N/A
Total200,000,000